Measurement, Correlates, and Health Outcomes of Medication Adherence Among Seniors
OBJECTIVE To provide a comprehensive review of the literature on the measurement, correlates, and health outcomes of medication adherence among community-dwelling older adults. DATA SOURCES Searches of MEDLINE, PubMed, and International Pharmaceutical Abstracts databases for English-language literat...
Gespeichert in:
Veröffentlicht in: | The Annals of pharmacotherapy 2004-02, Vol.38 (2), p.303-312 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE
To provide a comprehensive review of the literature on the measurement, correlates, and
health outcomes of medication adherence among community-dwelling older adults.
DATA SOURCES
Searches of MEDLINE, PubMed, and International Pharmaceutical
Abstracts databases for English-language literature (1966–December 2002) were
conducted using one or more of the following terms: elderly, adherence/nonadherence,
compliance/noncompliance, medication/drug, methodology/measurement, and
hospitalization.
STUDY SELECTION AND DATA EXTRACTION
From the above search, studies of medication adherence in community-dwelling seniors
were selected for review along with relevant publications from the reference lists of
articles identified in the initial database search.
DATA SYNTHESIS
Although several methods are available for the assessment of adherence, accurate
measurement continues to be difficult. The available evidence suggests that polypharmacy
and poor patient–healthcare provider relationships (including the use of multiple
providers) may be major determinants of nonadherence among older persons, with the
impact of most sociodemographic factors being negligible. There is little consensus
regarding other determinants of nonadherence. Relatively few high-quality investigations
have examined the associations between nonadherence and subsequent health outcomes.
Available data provide some support for increased health risks with nonadherence.
However, interventions to improve adherence have seldom demonstrated positive effects on
health outcomes.
CONCLUSIONS
There are few empirical data to support a simple systematic descriptor of the
nonadherent patient. The inconsistencies across studies may be attributable, in part, to
the inherent difficulties involved in the measurement of a behavioral risk factor such
as nonadherence. Future research in this area would be strengthened by incorporation of
detailed assessments of patient-reported reasons for nonadherence, the appropriateness
of drug regimens, and the effect of nonadherence on health outcomes. |
---|---|
ISSN: | 1060-0280 1542-6270 |
DOI: | 10.1345/aph.1D252 |